A Dual Macrophage Targeting Nanovector for Delivery of Oligodeoxynucleotides To Overcome Cancer-Associated Immunosuppression
Authors:
- 30 November 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 9 (49) , 42566-42576
Abstract
To overcome cancer-associated immunosuppression, we prepared a dual-targeting vector to deliver CpG oligodeoxynucleotides (ODN) to macrophages. The dual-targeting system composed of mannosylated carboxymethyl chitosan (MCMC)/hyaluronan (HA) for macrophage targeting and protamine sulfate (PS) for ODN complexation was prepared by self-assembly. The effects of ODN delivery on immune cells was studied in J774A.1 cells. Due to the enhanced delivery efficiency, the dual-targeting delivery system exhibits a higher immune stimulatory activity compared with the mono-targeting delivery system containing either MCMC or HA, resulting in dramatically enhanced secretion of pro-inflammatory cytokines and a successful shift to activated macrophages (M1). Besides macrophages, the influence of these delivery systems on tumor cells (MCF-7) was also investigated. In MCF-7 cells, the increased expressions of NF-κB, PIK3R3, p-Akt caused by activated NF-κB and PI3K/Akt signalings were observed. Nevertheless, up-regulated Fas as well as Fas-L may induce Fas/FasL-mediated apoptosis, which results in increased expressions of caspases in tumor cells.Keywords
Funding Information
- National Natural Science Foundation of China (51533006)
This publication has 67 references indexed in Scilit:
- Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast CancerJournal of Cellular Biochemistry, 2017
- Targeting tumor associated macrophages (TAMs) via nanocarriersJournal of Controlled Release, 2017
- Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapyAdvanced Drug Delivery Reviews, 2016
- Modulation of Macrophage Functional Polarity towards Anti-Inflammatory Phenotype with Plasmid DNA Delivery in CD44 Targeting Hyaluronic Acid NanoparticlesScientific Reports, 2015
- Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer ProgressionScientific Reports, 2015
- Macrophages and cancer: from mechanisms to therapeutic implicationsTrends in Immunology, 2015
- Macrophage biology in development, homeostasis and diseaseNature, 2013
- Cancer immunotherapy comes of ageNature, 2011
- Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonistsAdvanced Drug Delivery Reviews, 2009
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002